Get the Daily Brief
Latest Biotech News
AI-Integrated Lab-in-the-Loop Platforms Expand Biopharma Drug Discovery Capacity
Ginkgo Bioworks has partnered with Inductive Bio and Tangible Scientific to launch a unified AI-driven lab-in-the-loop drug discovery workflow aiming to streamline high-throughput experimentation,...
Breakthrough Study Links Brain Inflammation from High-Salt Diet to Hypertension
A pivotal study from McGill University demonstrates that excessive salt intake induces brain inflammation driving increases in blood pressure. This research challenges traditional kidney- and...
Multi-Ancestry Genomic Study Reveals Novel Genetic Loci Linked to Keloid Disease
An unprecedented multi-ancestry meta-analysis has identified novel genetic susceptibility loci associated with keloid formation, a complex fibroproliferative skin disorder. By integrating diverse...
AI-Powered Fluorescent Probes Illuminate Incretin Receptors in Pancreas and Brain
Researchers have engineered fluorescent dual agonist probes targeting GLP1R and GIPR receptors, enabling unprecedented visualization of incretin hormone action within pancreatic and neural...
Major Restructuring at CSL Includes Seqirus Spin-Off and Workforce Reduction
Australian pharma giant CSL announced a comprehensive restructuring plan involving the separation of its vaccine subsidiary Seqirus as an independent publicly listed company by mid-2026, alongside...
FDA Lifts Clinical Hold on Rocket Pharmaceuticals Gene Therapy Trial
The FDA has approved Rocket Pharmaceuticals to resume its pivotal Phase 2 gene therapy trial for Danon disease, a rare genetic disorder affecting multiple organs including the heart. The trial had...
Viking Therapeutics’ Oral Obesity Drug Data Sparks Investor Concern
Viking Therapeutics reported Phase 2 data for its oral obesity drug VK-2735 showing statistically significant weight loss of up to 12.2% after 13 weeks at the highest dose. However, the study...
CSL’s Vaccine Unit Spin-Off and Workforce Reductions Unveiled
Australian biopharma CSL announced a strategic overhaul involving the separation of its influenza vaccine business, Seqirus, into a standalone company projected to be completed by June next year....
Breakthroughs in Epigenomic and Single-Cell Technologies
Emerging companies and academic groups are advancing epigenomic analysis and single-cell technologies to enhance precision medicine and biological insights. Epigenica, a Swedish startup, is...
Advances in Neurodegenerative Disease Research and Therapies
Research continues to illuminate mechanisms and treatments for neurodegenerative diseases. Eli Lilly plans to replace Anne White, head of its neuroscience division, after her retirement in...
Emerging AI and Digital Technologies Transforming Bioprocessing and Drug Discovery
Industry leaders are leveraging AI and data analytics to transform biologics development and drug discovery. Sanofi's iCMC digital transformation program employs data, machine learning, and...
Cancer Innovations Highlight Molecular Targets and Diagnostic Advances
Recent studies cover therapeutic and diagnostic advances in oncology. Natera presented improved survival data in Signatera-positive bladder cancer patients receiving Tecentriq, progressing towards...
Innovations in Neonatal and Pediatric Care Technologies
Groundbreaking technologies are shaping neonatal and pediatric medicine. Virtual reality simulation for neonatal resuscitation training has been piloted, combining immersion with life-saving...
Environmental and Agricultural Biotechnology: New Frontiers
Researchers are unveiling new biotechnologies aimed at environmental sustainability and agricultural innovation. University of Missouri-led studies reveal poplar trees dynamically regulate wood...
AI and Automation Transform Bioprocessing: Sanofi’s Vision for Bioprocessing 4.0
At the Bioprocessing Summit in Boston, Sanofi’s digital transformation lead, Cenk Undey, outlined the integration of AI, data analytics, and automation to revolutionize biologics manufacturing....
Liquid Biopsy Innovation: Myriad Genetics and Angle Team on Tumor Cell Detection
Angle has entered a research collaboration with Myriad Genetics to co-develop liquid biopsy assays leveraging Angle’s Parsortix platform for circulating tumor cell (CTC) capture. The partnership...
Molecular You Secures $5 Million to Expand Advanced Biomarker Testing
Consumer health company Molecular You completed a $5 million Series A round led by Voloridge Health to enhance its blood test platform analyzing over 250 biomarkers for 26 health conditions and...
Graphene Advances Neuronal Maturation and Stimulation in Brain Organoids
UC San Diego researchers have pioneered Graphene-Mediated Optical Stimulation (GraMOS), a novel technique using light to activate and mature neurons grown on graphene-coated substrates. The method...
FDA Appoints Stephen Hahn as CEO of Radiopharmaceuticals Startup Nucleus RadioPharma
Former FDA Commissioner Stephen Hahn has been named CEO of Nucleus RadioPharma, a contract developer and manufacturer specializing in radiopharmaceuticals and radioligand therapies. These...
Sarepta Triggers $100 Million Milestone with Arrowhead on Myotonic Dystrophy Program
Sarepta Therapeutics announced significant progress on its SRP-1003 siRNA candidate for Myotonic Dystrophy type 1 (DM1), activating a $100 million milestone payment to partner Arrowhead...